CDK9 - cyclin dependent kinase 9 Gene
Species: Canis lupus familiaris (sub-species: familiaris)
Gene Type: protein coding
Gene ID: 100855805
CDK9 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_038678497.1 | XP_038534425.1 | cyclin-dependent kinase 9 |
CDK9 Protein Structure
STKc_CDK9
STKc_CDK9: cd07865 (5 - 314)
- 0
- 100
- 200
- 300
- 372 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cyclin-dependent kinase 9 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-16297A | Abemaciclib | Inhibitor | 99.97% | Yes |
| HY-10492 | Dinaciclib | Inhibitor | 99.80% | Yes |
| HY-16297 | Abemaciclib methanesulfonate | Inhibitor | 99.95% | Yes |
Clinical Phase
Bioactive Molecules
(27)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-112272A | Lerociclib dihydrochloride | Inhibitor | 98.51% | Phase 3 |
| HY-112272 | Lerociclib | Inhibitor | 96.42% | Phase 3 |
| HY-112088 | AZD4573 | Inhibitor | 99.98% | Phase 2 |
| HY-103712A | Samuraciclib hydrochloride | Inhibitor | 99.98% | Phase 2 |
| HY-X0009 | Tambiciclib | Inhibitor | 99.68% | Phase 2 |
| HY-50940 | AT7519 | Inhibitor | 99.69% | Phase 2 |
| HY-101212 | Fadraciclib | Inhibitor | 99.77% | Phase 2 |
| HY-137478 | KB-0742 | Inhibitor | 99.63% | Phase 2 |
| HY-137478A | KB-0742 dihydrochloride | Inhibitor | 98.77% | Phase 2 |
| HY-103712 | Samuraciclib | Inhibitor | 99.55% | Phase 2 |
| HY-103712B | Samuraciclib hydrochloride dihydrate | Inhibitor | 99.90% | Phase 2 |
| HY-50943 | AT7519 Hydrochloride | Inhibitor | 99.16% | Phase 2 |
| HY-103712C | Samuraciclib hydrochloride hydrate | Inhibitor | 99.88% | Phase 2 |
| HY-50940A | AT7519 TFA | Inhibitor | 99.75% | Phase 2 |
| HY-X0009A | Tambiciclib dimaleate | Inhibitor | 99.53% | Phase 2 |
| HY-16559A | Riviciclib | Inhibitor | / | Phase 2 |
| HY-10008 | SNS-032 | Inhibitor | 99.91% | Phase 1 |
| HY-138293 | SY-5609 | Inhibitor | 99.93% | Phase 1 |
| HY-10012 | AZD-5438 | Inhibitor | 99.91% | Phase 1 |
| HY-11001 | PHA-793887 | Inhibitor | 99.25% | Phase 1 |
| HY-12871B | Atuveciclib | Inhibitor | 99.75% | Phase 1 |
| HY-15504 | RGB-286638 | Inhibitor | 99.67% | Phase 1 |
| HY-111388B | Romaciclib hydrochloride | Inhibitor | 99.98% | Phase 1 |
| HY-12422 | Voruciclib | Inhibitor | 99.76% | Phase 1 |
| HY-103019B | (-)-Enitociclib | Inhibitor | 99.85% | Phase 1 |
| HY-15504A | RGB-286638 free base | Inhibitor | 98.09% | Phase 1 |
| HY-12422A | Voruciclib hydrochloride | Inhibitor | 99.26% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(157)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N0400 | Wogonin | Inhibitor | 99.83% | Unkown |
| HY-103618 | THZ531 | Inhibitor | 99.86% | Unkown |
| HY-12214A | NVP-2 | Inhibitor | 99.05% | Unkown |
| HY-103248 | Toyocamycin | Inhibitor | 99.27% | Unkown |
| HY-101257 | YKL-5-124 | Inhibitor | 99.53% | Unkown |
| HY-103019 | Enitociclib | Inhibitor | 99.89% | Unkown |
| HY-111388A | Romaciclib monohydrochloride | Inhibitor | 99.29% | Unkown |
| HY-123954 | BTX-A51 | Inhibitor | 98.58% | Unkown |
| HY-18340 | (R)-CR8 | Inhibitor | 99.52% | Unkown |
| HY-130709 | PROTAC CDK2/9 Degrader-1 | Degrader | 99.85% | Unkown |
| HY-130665 | TL12-186 | Inhibitor | 99.23% | Unkown |
| HY-13914 | Roniciclib | Inhibitor | 98.00% | Unkown |
| HY-143584 | AZ5576 | Inhibitor | 99.86% | Unkown |
| HY-15878 | LDC000067 | Inhibitor | 99.00% | Unkown |
| HY-144117 | GFB-12811 | Inhibitor | 98.04% | Unkown |
| HY-11009 | CGP60474 | Inhibitor | 98.90% | Unkown |
| HY-12445 | Asnuciclib | Inhibitor | 99.76% | Unkown |
| HY-13461A | PHA-767491 hydrochloride | Inhibitor | 99.49% | Unkown |
| HY-18340A | (R)-CR8 trihydrochloride | Inhibitor | 99.37% | Unkown |
| HY-13461 | PHA-767491 | Inhibitor | 99.97% | Unkown |
| HY-X0150 | JSH-150 | Inhibitor | 98.36% | Unkown |
| HY-103019A | (±)-Enitociclib | Inhibitor | 99.23% | Unkown |
| HY-173523 | KI-CDK9d-32 | Degrader | 99.03% | Unkown |
| HY-12280 | THZ2 | Inhibitor | 99.03% | Unkown |
| HY-16559 | Riviciclib hydrochloride | 99.08% | Unkown | |
| HY-112626 | CDK12-IN-2 | Inhibitor | 99.36% | Unkown |
| HY-13266A | BS-181 hydrochloride | Inhibitor | 99.93% | Unkown |
| HY-119940 | MC180295 | Inhibitor | 98.07% | Unkown |
| HY-103628 | PROTAC CDK9 Degrader-1 | Inhibitor | 99.55% | Unkown |
| HY-162919 | YK-2168 | Inhibitor | 98.05% | Unkown |
| HY-12293 | LY2857785 | Inhibitor | 99.21% | Unkown |
| HY-13231 | CDK9-IN-1 | Inhibitor | 98.52% | Unkown |
| HY-124639 | CDK9 inhibitor HH1 | Inhibitor | 99.69% | Unkown |
| HY-101257B | YKL-5-124 TFA | Inhibitor | 99.74% | Unkown |
| HY-162706 | BSJ-5-63 | Degrader | 99.97% | Unkown |
| HY-169244 | CDK-TCIP1 | Inhibitor | 98.86% | Unkown |
| HY-112403 | (S)-Roscovitine | Inhibitor | 99.15% | Unkown |
| HY-162037 | CDDD11-8 | Inhibitor | 99.62% | Unkown |
| HY-151069 | TMX-2039 | Inhibitor | 99.42% | Unkown |
| HY-139329 | CDK12-IN-6 | Inhibitor | 99.15% | Unkown |
| HY-139980 | CDK9-IN-13 | Inhibitor | 99.94% | Unkown |
| HY-153260 | TP-1287 | Inhibitor | 95.93% | Unkown |
| HY-18944 | FIT-039 | Inhibitor | 99.56% | Unkown |
| HY-13033 | CDK-IN-2 | Inhibitor | 99.27% | Unkown |
| HY-14372 | BS-194 | Inhibitor | 99.13% | Unkown |
| HY-16462 | CDK9-IN-2 | Inhibitor | 98.72% | Unkown |
| HY-12871 | Atuveciclib Racemate | Inhibitor | 98.48% | Unkown |
| HY-117203A | CDK12-IN-E9 | Inhibitor | 99.71% | Unkown |
| HY-102039 | CDK9-IN-8 | Inhibitor | 99.16% | Unkown |
| HY-100950 | ABC1183 | Inhibitor | 99.62% | Unkown |
| HY-111388 | SEL120-34A | Inhibitor | 99.49% | Unkown |
| HY-178861 | dCDK9-202 | Degrader | 99.25% | Unkown |
| HY-111427 | CDK8/19-IN-1 | Inhibitor | 98.08% | Unkown |
| HY-168518 | PROTAC CDK9 degrader-9 | Degrader | 99.25% | Unkown |
| HY-126251 | CDK9-IN-7 | Inhibitor | 98.05% | Unkown |
| HY-100429 | CAN508 | Inhibitor | 99.71% | Unkown |
| HY-130852 | CDK9-IN-11 | Inhibitor | 97.02% | Unkown |
| HY-123955 | Casein Kinase inhibitor A86 | Inhibitor | 99.26% | Unkown |
| HY-155787 | SHR5428 | Inhibitor | 99.80% | Unkown |
| HY-119715 | AG-012986 | Inhibitor | 99.78% | Unkown |
| HY-112811 | PROTAC CDK9 degrader-2 | Inhibitor | 99.22% | Unkown |
| HY-15241 | NVP-LCQ195 | Inhibitor | 98.88% | Unkown |
| HY-176165 | CDK9/EZH2-IN-1 | Inhibitor | 99.08% | Unkown |
| HY-115714 | CDK9-IN-12 | Inhibitor | 99.65% | Unkown |
| HY-176142 | YX0798 | Inhibitor | 98.90% | Unkown |
| HY-139328 | CDK12-IN-5 | Inhibitor | 98.03% | Unkown |
| HY-103646 | CK7 | Inhibitor | 99.72% | Unkown |
| HY-13266 | BS-181 | Inhibitor | 98.10% | Unkown |
| HY-115729 | PROTAC CDK9 ligand-1 | Ligand | 99.75% | Unkown |
| HY-143585 | CDK9-IN-14 | Inhibitor | 99.91% | Unkown |
| HY-12843 | Bohemine | Inhibitor | 98.93% | Unkown |
| HY-130850 | CDK9-IN-10 | Inhibitor | 98.09% | Unkown |
| HY-153556 | GW297361 | Inhibitor | 98.13% | Unkown |
| HY-164906 | TMX-2138 | Degrader | / | Unkown |
| HY-142696 | CDK6/PIM1-IN-1 | Inhibitor | / | Unkown |
| HY-112450 | Olomoucine II | Inhibitor | 98.0% | Unkown |
| HY-151436 | ZLMT-12 | Inhibitor | / | Unkown |
| HY-110368 | BS-181 dihydrochloride | Inhibitor | / | Unkown |
| HY-130981 | FN-1501-propionic acid | / | Unkown | |
| HY-130001 | CDK9-IN-9 | Inhibitor | / | Unkown |
| HY-131063 | CDK6/9-IN-1 | Inhibitor | / | Unkown |
| HY-178733 | A-1592668 | Inhibitor | / | Unkown |
| HY-137478B | KB-0742 hydrochloride | Inhibitor | / | Unkown |
| HY-119831 | Rohitukine | Inhibitor | / | Unkown |
| HY-147794 | CDK9-IN-41 | Inhibitor | 98.84% | Unkown |
| HY-178452 | PROTAC CDK4/6/9 degrader 1 | Degrader | / | Unkown |
| HY-163856 | CDK7-IN-30 | Inhibitor | / | Unkown |
| HY-150562 | CDK9-IN-19 | Inhibitor | / | Unkown |
| HY-181231 | PROTAC CDK9 degrader-12 | Degrader | / | Unkown |
| HY-175013 | CDK6/9-IN-2 | Inhibitor | / | Unkown |
| HY-176736 | CDK9-IN-40 | Inhibitor | / | Unkown |
| HY-121081A | BAY-1112054 hydrochloride | Inhibitor | / | Unkown |
| HY-173348 | BLINK15 | Inhibitor | / | Unkown |
| HY-182470 | AG-012986 dihydrochloride | Inhibitor | / | Unkown |
| HY-150641 | CDK-IN-9 | Inhibitor | / | Unkown |
| HY-173481 | CDK9-IN-37 | Inhibitor | / | Unkown |
| HY-180124 | CDK8-IN-20 | Inhibitor | / | Unkown |
| HY-178516 | PROTAC CDK4/6/9 degrader 2 | Degrader | / | Unkown |
| HY-179023 | CDK9-IN-45 | Inhibitor | / | Unkown |
| HY-183698 | CDK9-IN-51 | Inhibitor | / | Unkown |
| HY-161768 | VCC972839:01 | Inhibitor | / | Unkown |
| HY-149495 | CP-07 | Degrader | / | Unkown |
| HY-180817 | CDK2-IN-55 | Inhibitor | 98.91% | Unkown |
| HY-170815 | CDK4/9-IN-1 | Inhibitor | / | Unkown |
| HY-156795 | PROTAC CDK9/CycT1 Degrader-2 | Inhibitor | / | Unkown |
| HY-179375 | LCI133 | Inhibitor | / | Unkown |
| HY-178112 | CDK2-IN-47 | Inhibitor | / | Unkown |
| HY-185339 | CDK9-IN-48 | Inhibitor | / | Unkown |
| HY-161595 | CDK5-IN-4 | Inhibitor | / | Unkown |
| HY-180912 | HS-36 | Inhibitor | / | Unkown |
| HY-181275 | CDK9 ligand 4 | Ligand | / | Unkown |
| HY-172891 | CDK9/HDAC1/HDAC3-IN-1 | Inhibitor | / | Unkown |
| HY-182810 | CDK9 ligand 5 | Ligand | / | Unkown |
| HY-161463 | CDK2-IN-28 | Inhibitor | / | Unkown |
| HY-151898 | CDK4/6-IN-14 | Inhibitor | / | Unkown |
| HY-151878 | CDK7-IN-20 | Inhibitor | / | Unkown |
| HY-164619 | CDK9-IN-34 | Inhibitor | / | Unkown |
| HY-139327 | CDK12-IN-4 | Inhibitor | / | Unkown |
| HY-136841 | SLM6 | Inhibitor | / | Unkown |
| HY-157980 | CDK9-IN-32 | Inhibitor | / | Unkown |
| HY-173065 | CDK9-IN-36 | Inhibitor | / | Unkown |
| HY-168845 | CDK2/9-IN-1 | Inhibitor | / | Unkown |
| HY-145408 | CDK7/9-IN-1 | Inhibitor | / | Unkown |
| HY-149962 | PROTAC CDK9 degrader-5 | Inhibitor | / | Unkown |
| HY-151984 | CDK9-IN-22 | Inhibitor | / | Unkown |
| HY-182986 | LS-Q2 | Inhibitor | / | Unkown |
| HY-179633 | ZLMT-72 | Inhibitor | / | Unkown |
| HY-183699 | CDK9-IN-52 | Inhibitor | / | Unkown |
| HY-178039 | CDK9-IN-42 | Inhibitor | / | Unkown |
| HY-155153 | CDK9-IN-24 | Inhibitor | / | Unkown |
| HY-153426 | CDK9-IN-23 | Inhibitor | / | Unkown |
| HY-149870 | PROTAC CDK9 degrader-8 | Inhibitor | / | Unkown |
| HY-150573 | CDK2-IN-12 | Inhibitor | / | Unkown |
| HY-181569 | CDK9-IN-46 | Inhibitor | / | Unkown |
| HY-161379 | CLZX-205 | Inhibitor | / | Unkown |
| HY-111356 | IIIM-290 | Inhibitor | / | Unkown |
| HY-150889 | CDK9 ligand 1 | Inhibitor | / | Unkown |
| HY-178499 | CDK9-IN-44 | Inhibitor | / | Unkown |
| HY-108375 | CDK9 ligand-Linker Conjugate 1 | Ligand | / | Unkown |
| HY-185340 | CDK9-IN-49 | Inhibitor | / | Unkown |
| HY-150948 | CDK12 ligand-2 | Ligand | / | Unkown |
| HY-173347 | BLINK11 | Inhibitor | / | Unkown |
| HY-176451 | CDK9 degrader-1 | Degrader | / | Unkown |
| HY-153718 | KI-ARv-03 | Inhibitor | / | Unkown |
| HY-156083 | CDK9-IN-28 | Inhibitor | / | Unkown |
| HY-168896 | CDK9 autophagic degrader 1 | Degrader | / | Unkown |
| HY-183710 | CDK9-IN-50 | Inhibitor | / | Unkown |
| HY-162619 | CDK9-IN-33 | Inhibitor | / | Unkown |
| HY-147771 | ZLWT-37 | Inhibitor | / | Unkown |
| HY-170942 | CDK9/PARP-IN-1 | Inhibitor | / | Unkown |
| HY-149963 | PROTAC CDK9 degrader-6 | Inhibitor | / | Unkown |
| HY-181645 | CDK12-IN-9 | Inhibitor | / | Unkown |
| HY-177780 | Cyclin K degrader 2 | Degrader | / | Unkown |
| HY-123034 | CDKI-83 | Inhibitor | / | Unkown |
| HY-11001A | PHA-793887 hydrochloride | Inhibitor | / | Unkown |
| HY-123826 | CCT68127 | Inhibitor | / | Unkown |
| HY-119120 | JTK-101 | Inhibitor | / | Unkown |